Back to top

Tale of the Tape

Zacks Equity Research

Cara Therapeutics (CARA) Catches Eye: Stock Moves Up 12%
October 06, 2016


Trades from $3

Cara Therapeutics Inc. (CARA - Snapshot Report) was a big mover last session, as the company saw its shares rise almost 12% on the day. The news led to far more shares changing hands than in a normal session, resulting in solid volume. This continues the recent trend for the company as the stock is now up 70% in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days while the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cara Therapeutics has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

A better-ranked stock in the same industry is Anika Therapeutics Inc. (ANIK - Snapshot Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CARA going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>